Tilray Brands (TLRY) Current Assets (2017 - 2026)
Tilray Brands (TLRY) posted Current Assets of $718.8 million for Q1 2026, down 1.45% on a QoQ basis from $729.3 million in Q4 2025.
Tilray Brands (TLRY) Current Assets (2017 - 2026) Analysis & Trends
Tilray Brands' Current Assets history runs 10 years deep, the most recent figure standing at $718.8 million for Q1 2026.
- Quarterly Current Assets changed N/A year-over-year to $718.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $718.8 million (changed N/A YoY) and the FY2025 annual result came in at $688.6 million, up 1.61% from the prior year.
- Current Assets was $718.8 million for Q1 2026 at Tilray Brands, down from $729.3 million in the prior quarter.
- Across five years, Current Assets topped out at $910.9 million in Q3 2022 and bottomed at $631.2 million in Q1 2024.
- A 5-year average of $738.0 million and a median of $722.3 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets advanced 15.03% — and 2023, when it decreased 21.2%.
- Tilray Brands' Current Assets stood at $814.7 million in 2022, then slipped by 21.2% to $642.0 million in 2023, then grew by 10.17% to $707.3 million in 2024, then rose by 3.11% to $729.3 million in 2025, then dropped by 1.45% to $718.8 million in 2026.
- Business Quant data shows TLRY's Current Assets at $718.8 million in Q1 2026, $729.3 million in Q4 2025, and $701.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 718.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 718.76 Mn |
| Nov 30, 2025 | 729.32 Mn |
| Aug 31, 2025 | 701.14 Mn |
| May 31, 2025 | 688.63 Mn |
| Nov 30, 2024 | 707.34 Mn |
| Aug 31, 2024 | 725.88 Mn |
| May 31, 2024 | 677.71 Mn |
| Feb 29, 2024 | 631.21 Mn |
| Nov 30, 2023 | 642.03 Mn |
| Aug 31, 2023 | 829.26 Mn |
| May 31, 2023 | 773.03 Mn |
| Feb 28, 2023 | 758.51 Mn |
| Nov 30, 2022 | 814.71 Mn |
| Aug 31, 2022 | 910.88 Mn |
| May 31, 2022 | 803.50 Mn |
| Feb 28, 2022 | 695.79 Mn |
| Nov 30, 2021 | 708.28 Mn |
| Aug 31, 2021 | 844.62 Mn |
| May 31, 2021 | 883.61 Mn |
| May 31, 2020 | 581.63 Mn |